Alpha 2.0
Login Register
» Articles » PMID: 27606306

Summary of the Published Indian Data on Chronic Myeloid Leukemia

Overview
Journal South Asian J Cancer
Specialty Oncology
Date 2016 Sep 9
PMID 27606306
Citations 7
Authors
Manish K Singhal
Manju Sengar
Reena Nair
Affiliations
Soon will be listed here.
Abstract

Chronic myelogenous leukemia (LML) was recognized as a distinct entity in the mid-1800s. Since Nowell and Hunagerford initiated their research on CML in1960 our understanding in CML has been increasing. Imatinib became the preferred treatment from 2000 onwards as a result of its unprecedented success. The lack of structured Indian data on CML led to the formation of a CML data cansortuim which invited CML data albiet retro spartive form around the country including major cancer service providers both government and private. We provide a summary of published Indian data on CML here.

Citing Articles

Evaluation of visual evoked potential in chronic myeloid leukemias.

Agrawal A, Aggarwal S, Singh R, Goyal J, Garg S Oman J Ophthalmol. 2023; 16(3):489-494.

PMID: 38059114 PMC: 10697254. DOI: 10.4103/ojo.ojo_245_22.

Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia.

Narasimhan M, Khamkar V, Tilwani S, Dalal S, Shetty D, Subramanian P J Cell Commun Signal. 2021; 16(2):207-222.

PMID: 34596797 PMC: 8891420. DOI: 10.1007/s12079-021-00647-x.

Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations.

Asif M, Hussain A, Wali A, Ahmed N, Ali I, Iqbal Z Anal Cell Pathol (Amst). 2021; 2021:4909012.

PMID: 34422550 PMC: 8378985. DOI: 10.1155/2021/4909012.

Exovesicular-Shh confers Imatinib resistance by upregulating Bcl2 expression in chronic myeloid leukemia with variant chromosomes.

Anusha , Dalal H, Subramanian S, V P S, Gowda D, H K Cell Death Dis. 2021; 12(3):259.

PMID: 33707419 PMC: 7952724. DOI: 10.1038/s41419-021-03542-w.

Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India.

Phukan A, Mandal P, Dolai T Ann Hematol. 2020; 100(1):85-96.

PMID: 33025163 DOI: 10.1007/s00277-020-04289-8.

References
1.
Aziz Z, Iqbal J, Akram M, Saeed S . Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country. Cancer. 2007; 109(6):1138-45. DOI: 10.1002/cncr.22498. View
2.
Ray S, Chakraborty P, Chaudhuri U, Ganesh . Report of chronic myeloid leukemia in chronic phase from Eastern India, Institute of Hematology and Transfusion Medicine, Kolkata, 2001-2009. Indian J Med Paediatr Oncol. 2014; 34(3):175-6. PMC: 3902617. DOI: 10.4103/0971-5851.123721. View
3.
Rajappa S, Varadpande L, Paul T, Jacob R, Digumarti R . Report of chronic myeloid leukemia in chronic phase from Dr. Senthil Rajappa, 2002-2009. Indian J Med Paediatr Oncol. 2014; 34(3):208-10. PMC: 3902628. DOI: 10.4103/0971-5851.123745. View
4.
Dattatreya P, Nirni S . Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010. Indian J Med Paediatr Oncol. 2014; 34(3):204-5. PMC: 3902626. DOI: 10.4103/0971-5851.123742. View
5.
Ganesan P, Rejiv R, Manjunath N, Sanju C, Sagar T . Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009. Indian J Med Paediatr Oncol. 2014; 34(3):206-7. PMC: 3902627. DOI: 10.4103/0971-5851.123744. View